|
ZKSCAN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.67679999998993E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.657700E-03 |
| Normal-vs-Stage2 |
5.232600E-04 |
| Normal-vs-Stage3 |
5.22559999716066E-08 |
| Normal-vs-Stage4 |
1.79110000164684E-08 |
| Stage1-vs-Stage2 |
2.909800E-01 |
| Stage1-vs-Stage3 |
3.216100E-03 |
| Stage1-vs-Stage4 |
6.632900E-04 |
| Stage2-vs-Stage3 |
3.262600E-01 |
| Stage2-vs-Stage4 |
1.320600E-01 |
| Stage3-vs-Stage4 |
4.551600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.53769999997355E-06 |
| Normal-vs-AfricanAmerican |
2.58600000002662E-06 |
| Normal-vs-Asian |
7.801600E-01 |
| Caucasian-vs-AfricanAmerican |
1.839820E-01 |
| Caucasian-vs-Asian |
6.604000E-02 |
| AfricanAmerican-vs-Asian |
1.597630E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.73480000004367E-06 |
| Normal-vs-Female |
5.76369999999438E-05 |
| Male-vs-Female |
4.051000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.000100E-03 |
| Normal-vs-Age(41-60Yrs) |
8.585900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.7979999999973E-07 |
| Normal-vs-Age(81-100Yrs) |
1.208820E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.075000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.696800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.564000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.280200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.197390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.436000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.298400E-01 |
| Normal-vs-Grade 2 |
1.156060E-03 |
| Normal-vs-Grade 3 |
1.40770000001122E-06 |
| Normal-vs-Grade 4 |
4.86629958551532E-10 |
| Grade 1-vs-Grade 2 |
3.846400E-01 |
| Grade 1-vs-Grade 3 |
1.175220E-01 |
| Grade 1-vs-Grade 4 |
3.743400E-03 |
| Grade 2-vs-Grade 3 |
1.125220E-01 |
| Grade 2-vs-Grade 4 |
1.044970E-04 |
| Grade 3-vs-Grade 4 |
1.043650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.503800E-03 |
| Normal-vs-ccB subtype |
1.631230E-04 |
| ccA subtype-vs-ccB subtype |
1.320020E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.54449999999873E-05 |
| Normal-vs-N1 |
1.673620E-02 |
| N0-vs-N1 |
6.860200E-01 |
|
|
